drugset / Trial / NCT04245319

Combined Effect of Acitretin and Narrow Band Ultraviolet B on Vitiligo Repigmentation

NCT04245319

Unknown 20 enrolled Cairo University
RandomizedParallel-groupTriple-blindTreatment

Summary

Since abnormal keratinocyte (KC) proliferation and differentiation as well as defective E cadherin expression were reported in vitiligo lesions, the investigators set to study the potential efficacy of combining Retinoids, which are known to improve KC proliferation and differentiation and increase the expression of adhesion molecules, with narrowband UVB in the treatment of vitiligo.

Timeline

Start
2020-01-01
Primary completion
2021-11-30
Completion
2021-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Acitretin Small molecule 0.3 mg/kg